Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Rating) saw unusually large options trading activity on Friday. Investors purchased 2,261 call options on the company. This represents an increase of approximately 1,304% compared to the average daily volume of 161 call options. Aeglea BioTherapeutics Stock Performance NASDAQ AGLE traded down $0.05 during trading hours on Friday, hitting […]
Aeglea BioTherapeutics Announces Grant of Inducement Awards streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE) today announced that, in connection with the acquisition of Spyre Therapeutics, Inc..
/PRNewswire/ Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other.